CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Los Angeles-based AIDS Healthcare Foundation announced Tuesday that it has filed a federal antitrust lawsuit against Abbott Laboratories for raising the price of its HIV protease inhibitor Norvir by 400%. Critics of the price hike say Abbott is unfairly trying to raise the price of other antiretroviral drug therapies, which commonly use small doses of Norvir to boost the effectiveness of other protease inhibitors, and drive cost-conscious HIV patients to Abbott's protease inhibitor Kaletra. Kaletra, which was not increased in price, already contains a small amount of Norvir in the same pill to boost the medication's efficacy. The lawsuit seeks unspecified damages and a court order setting the price of Norvir within "reasonable financial reach of the HIV-infected public. "Abbott's 400% increase for Norvir, from a cost of roughly $50 per month to nearly $250 per month, is purely and simply a move to wield its patent and monopoly power in the AIDS drug market and increase Abbott's own profits on this key AIDS drug," AHF president Michael Weinstein said. "Norvir...was developed with the help of substantial government underwriting and grants, a taxpayer investment which will now sadly benefit the corporate coffers of Abbott at the expense--literally--of the lives of millions of people living with HIV/AIDS." Abbott officials say the price of the drug was increased to both better reflect its expanding role in antiretroviral therapy and to generate income for the company to conduct research and development on additional drugs, including new HIV treatments. Company spokeswoman Laureen Cassidy dismissed the AHF lawsuit as "completely without merit" and said it "jeopardizes the long-term interests of AIDS patients." More than 200 HIV specialists have announced a boycott of Abbott drugs over the Norvir price hike, including banning company sales representatives from their offices and pulling out of clinical trials of medications developed by Abbott. In addition, the attorneys general from New York and Illinois are investigating whether the company is wrongly attempting to drive HIV-positive consumers to purchase Kaletra by making other antiretroviral drug combinations unaffordable.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
17 Celebs Who Are Out & Proud of Their Trans & Nonbinary Kids
November 30 2023 10:41 AM
Which State Is the Queerest? These Are the States With the Most LGBTQ+ People
December 11 2023 10:00 AM
These 27 Senate Hearing Room Gay Sex Jokes Are Truly Exquisite
December 17 2023 3:33 PM
10 Cheeky and Homoerotic Photos From Bob Mizer's Nude Films
November 18 2023 10:05 PM
42 Flaming Hot Photos From 2024's Australian Firefighters Calendar
November 10 2023 6:08 PM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
These Are the 5 States With the Smallest Percentage of LGBTQ+ People
December 13 2023 9:15 AM
25 pics of hot, shirtless celebs just to remind us of warmer weather
January 14 2024 10:47 AM
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
05/05/24
May 05 2024 10:58 PM
Mississippi Republicans pass anti-trans bathroom bill at last-minute
May 04 2024 11:39 AM
Who is Jane Rigby, the lesbian scientist who just received a Medal of Freedom?
May 04 2024 11:22 AM